Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Investigation, Limb discomfort, Oxygen saturation, Oxygen saturation decreased
Clinical narrative: oxygen saturation decreased; pale; diaphoretic; lightheaded; weak; feel like l'm going to faint; Heart rate decreased; that his legs felt heavy; he felt tired; This is a spontaneous report from a contactable other health care professional. A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0101) via intramuscular route, administered in right arm on 06Aug2021 13:30 (at the age of 41-year-old) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient had no allergies to vaccine or vaccine components.   On 06Aug2021 13:42 the patient had oxygen saturation decreased, he was pale, diaphoretic, lightheaded, weak, feel like he was going to faint. After getting up to walk, HR (heart rate) and oxygen saturation decreased briefly (less than a minute). Blood pressure remained stable. Patient visited Doctor or other health care professional office/ clinic visit. Taken via wheelchair to Lab, assisted to stretcher chair with feet up, initial: 112/66, HR54, O2 Room air 99 percentage, Departure: 129/74, HR 51, O2 92 percentage RA and kept under direct RN observation for an hour, after standing and walking down the hall at 2pm with RN, Client states that legs felt heavy and he felt tired. O2 SAT while walking 91 percentage HR 51. After returning from walk, clients states he felt OK, But tired. Briefly after 02 SAT Dropped to 87percentage and HR to 47 and then back up after a few seconds to 95 percentage, HR 51. Oxygen saturation and HR Fluctuation between 90-99 percentage and 50-54 BP. BPM after this occurence although, alert and oriented throughout, expressed concern to wife regarding bradycardia, and room air oxygen saturation and offered to call (Name withheld). V-Safe Brochure with wife and instructed to report. assisted client to wheelchair and transported to private vehicle. Lab data included: BP (Illegible), HR 54, 60, 55, 51, 54, Resp: 16, 16, 10, 16, O2 Sat 99. 99, 98, 91, 95 (Captured as per best understanding), Oxygen Started: No, CPR indicated: No. Disposition: Stable, symptoms not completely resolved. Patient status on departure: (Illegible), oriental x3. calm, answers questions appropriately. Outcome of the events was unknown.; Sender's Comments: Based on temporal association and known safety profile of the product, a contribution from the suspect drug bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), to the reported event oxygen saturation decreased cannot be completely excluded.The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.